TherapeuticsMD to be acquired by EW Healthcare Partners for $10.00/share in all-cash deal

TherapeuticsMD, Inc.

Offer price of $10.00 per share represents 367.3% premium over May 27 closing price.
Total enterprise value approx. $177 million; tender offer to commence by June 6, 2022.
Board unanimously approved; no stockholder vote required under Nevada law.
Financing: $93M equity commitment from EW; Sixth Street debt amended with interest pause and maturity extended to July 13, 2022.
If merger fails to close by July 13, 2022, events of default under financing agreement could impact going concern.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.